PharmaLink Conference

项目摘要 PharmaLink大会的主要目标是： 与美国食品和药物管理局和业界的开放式协作和接触，讨论制药挑战和 机遇。 为制药业和整个医疗保健领域不断增加的问题确定创新的解决方案。 AFDO建议PhamaLink会议计划遵循以下格式： 在2023年至2024年期间，将举行一次面对面的会议，介绍情况并推动 关于确定和构建创新和协作解决方案的讨论 医药行业推进患者护理。 每届大会期间，将有来自行业各个领域的130多名医药行业领袖前来 共同围绕在以下合作机会中出现的问题进行创新 行业和监管机构。

Project Summary The key objectives of the PharmaLink Conference are:  Open collaboration and engagement with FDA and industry to discuss pharmaceutical challenges and opportunities.  Identify innovative solutions for rising issues in the pharmaceutical industry and across healthcare. AFDO proposes the PhamaLink Conference plan to follow this format:  During years 2023-2024 there will be an in-person conference with presentations and facilitated discussions on identifying and building innovative and collaborative solutions to be used in the pharmaceutical industry to advance patient care. During each conference, a group of 130+ Pharmaceutical leaders from all areas of the industry will come together to lead innovation around the issues surfaced during the collaborative opportunities between industry and regulators.